GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Y

Ypsomed Holding YPSN.SW · CHF

Health Care · SIX · 🇨🇭 Switzerland

Compare

394.80

+0.10%

Close of 9 Nov 2026, in CHF

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CHF, from our data supplier.

FY2026

Revenue

CHF 731.0m

FY2017FY2026

Net income

CHF 221.9m

FY2017FY2026

Free cash flow

−CHF 16.3m

FY2017FY2026

Shareholders' equity

CHF 748.1m

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
RevenueCHF 731.0mCHF 748.9mCHF 548.5mCHF 497.5mCHF 464.8mCHF 403.7mCHF 394.3mCHF 453.8mCHF 466.1mCHF 389.6m
Gross profitCHF 314.6mCHF 292.1mCHF 189.1mCHF 140.6mCHF 113.8mCHF 94.8mCHF 91.0mCHF 156.4mCHF 139.8mCHF 125.5m
Research and developmentCHF 40.0mCHF 33.6mCHF 30.5mCHF 29.0mCHF 22.0mCHF 16.8mCHF 42.0mCHF 56.8mCHF 40.6mCHF 38.7m
Operating incomeCHF 246.1mCHF 112.9mCHF 86.2mCHF 60.6mCHF 28.6mCHF 9.3mCHF 1.8mCHF 73.2mCHF 60.9mCHF 55.3m
Net incomeCHF 221.9mCHF 87.5mCHF 78.4mCHF 51.3mCHF 23.1mCHF 5.8mCHF 11.7mCHF 60.1mCHF 52.1mCHF 46.2m
Diluted earnings per share16.376.415.743.761.700.460.934.774.133.67

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assetsCHF 1.35bnCHF 1.33bnCHF 1.10bnCHF 861.9mCHF 756.9mCHF 717.7mCHF 678.2mCHF 587.7mCHF 500.2mCHF 421.8m
Cash and short-term investmentsCHF 28.6mCHF 36.5mCHF 74.0mCHF 25.2mCHF 17.0mCHF 22.4mCHF 22.3mCHF 12.1mCHF 32.1mCHF 38.9m
Total liabilitiesCHF 598.5mCHF 650.7mCHF 483.7mCHF 299.5mCHF 364.4mCHF 322.3mCHF 292.9mCHF 208.9mCHF 158.7mCHF 120.0m
DebtCHF 260.8mCHF 267.0mCHF 256.0mCHF 157.0mCHF 267.0mCHF 215.0mCHF 193.0mCHF 122.0mCHF 59.0mCHF 37.1m
Shareholders' equityCHF 748.1mCHF 679.7mCHF 617.7mCHF 562.3mCHF 392.5mCHF 395.4mCHF 375.2mCHF 378.8mCHF 341.5mCHF 301.8m
Shares outstanding14m14m14m14m14m13m13m13m13m13m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operationsCHF 306.8mCHF 148.2mCHF 163.2mCHF 129.5mCHF 85.7mCHF 85.8mCHF 49.1mCHF 59.9mCHF 53.3mCHF 75.1m
Capital spending−CHF 323.1m−CHF 277.1m−CHF 195.3m−CHF 169.2m−CHF 127.4m−CHF 126.6m−CHF 118.7m−CHF 106.8m−CHF 51.0m−CHF 27.5m
Free cash flow−CHF 16.3m−CHF 128.9m−CHF 32.1m−CHF 39.6m−CHF 41.7m−CHF 40.8m−CHF 69.6m−CHF 46.9mCHF 2.2mCHF 47.6m
Dividends paid−CHF 30.0m−CHF 27.3m−CHF 17.7m−CHF 8.2m−CHF 14.7m−CHF 2.5m−CHF 6.9m−CHF 17.6m−CHF 16.4m−CHF 12.6m

Latest quarters

By quarter end

Mar 2026Sept 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023
RevenueCHF 368.3mCHF 362.7mCHF 212.4mCHF 212.4mCHF 162.0mCHF 162.0mCHF 293.1mCHF 146.5m
Gross profitCHF 164.4mCHF 150.2mCHF 87.3mCHF 87.3mCHF 58.7mCHF 58.7mCHF 101.2mCHF 65.9m
Operating incomeCHF 109.6mCHF 75.0mCHF 36.2mCHF 36.2mCHF 20.3mCHF 20.3mCHF 46.3mCHF 23.2m
Net incomeCHF 82.8mCHF 139.1mCHF 27.5mCHF 27.5mCHF 16.3mCHF 16.3mCHF 41.8mCHF 20.9m
Diluted earnings per share6.1110.192.012.011.191.193.061.53
Cash from operationsCHF 176.0mCHF 130.0mCHF 81.0mCHF 40.0mCHF 66.0mCHF 33.0mCHF 89.0mCHF 44.0m
Capital spending−CHF 169.0m−CHF 126.0m−CHF 53.0m−CHF 53.0m−CHF 49.0m−CHF 49.0m−CHF 66.0m−CHF 33.0m
Free cash flowCHF 7.0mCHF 4.0mCHF 28.0m−CHF 13.0mCHF 17.0m−CHF 16.0mCHF 23.0mCHF 11.0m
Total assetsCHF 1.35bnCHF 1.21bnCHF 1.33bnCHF 1.33bnCHF 1.18bnCHF 1.18bnCHF 1.10bnCHF 1.09bn
Cash and short-term investmentsCHF 28.6mCHF 36.3mCHF 36.5mCHF 36.5mCHF 52.3mCHF 52.3mCHF 74.0mCHF 74.0m
DebtCHF 260.8mCHF 110.0mCHF 367.0mCHF 267.0mCHF 325.2mCHF 325.2mCHF 256.0mCHF 256.0m
Shareholders' equityCHF 748.1mCHF 807.2mCHF 679.7mCHF 679.7mCHF 621.9mCHF 621.9mCHF 617.7mCHF 617.7m

Financial ratios

Data as of 19 Oct 2026

FY2026FY2025FY2024FY2023FY2022FY2021
Gross margin43.0%39.0%34.5%28.3%24.5%23.5%
Operating margin33.4%14.8%15.8%11.8%6.1%2.3%
Net margin30.4%11.7%14.3%10.3%5.0%1.4%
Return on equity29.7%12.9%12.7%9.1%5.9%1.5%
Return on assets16.5%6.6%7.1%5.9%3.1%0.8%
Free cash flow yield12.3%8.2%6.9%5.8%4.1%4.4%
Revenue growth-2.4%36.5%10.3%7.0%15.2%2.4%
Earnings growth153.6%11.7%52.8%121.9%297.6%-50.5%
Current ratio1.07x0.86x0.77x0.80x0.82x0.68x
Debt to equity0.35x0.54x0.29x0.24x0.63x0.54x
Equity ratio55.6%51.1%56.1%65.2%51.9%55.1%
Interest coverage76.75x16.70x17.21x25.52x12.62x4.55x
R&D as a share of sales5.5%4.5%5.6%5.8%4.7%4.2%
Buybacks as a share of market value0.7%-0.0%-0.0%-0.3%-7.4%-0.3%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue13.7%12.6%8.1%
Operating income59.5%92.7%18.7%
Net income63.0%107.2%20.0%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin41.0%37.1%33.7%32.4%
Operating margin24.3%20.0%16.0%14.3%
Net margin20.9%17.4%13.8%12.4%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings24.551.257.180.799.5405.6159.227.428.043.6
Price to sales7.56.08.28.34.95.84.73.63.15.2

Dividends and splits

Per share, in the currency the company pays

Paid for 18 years. Last went ex-dividend on 3 Jul 2026.

FY2027FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Paid in the year4.401.101.000.650.300.580.100.55

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.